Trials / Terminated
TerminatedNCT05489250
The PLATON Network
The Platform for Analyzing Targetable Tumor Mutations Network (Main-study)
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 565 (actual)
- Sponsor
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The PLATON Network study is designed to elevate personalized therapy based on genomic tumor profiles in gastrointestinal cancer patients. Hereby, PLATON's study-design focuses on the patient's tumor molecular profiling. Within the network a web application will be developed to link clinical investigators and information on study sites, cancer patients and genetic alteration data, as well as available clinical trials at PLATON's study sites.
Detailed description
The PLATON Network is established as permanent open, multicenter, prospective, cohort study of patients with gastrointestinal cancer. The study design includes a study-specific biobank and a shared platform infrastructure for associated sub-studies and analysis projects. Within PLATON results of genetic tests of different research projects like the PLATON pilot-study (NCT04484636) as well as Next-generation deep sequencing (NGS) according to local protocols will be documented - compiling genomic tumor-profiles including tumor mutational burden (TMB) and microsatellite instability (MSI). The PLATON Network infrastructure is designed to increase the likelihood of treating the patients with an individualized therapy in available clinical studies. Therefore, molecular profiling must go hand in hand with inter-linking physicians and increasing inter-centre transparency. The feasibility of this approach will be tested in the PLATON Network, keeping in mind the vision of cancer patients receiving the best available, scientifically founded, biomarker-based care, tailored to his or her individual needs.
Conditions
- Hepatocellular Cancer
- Cholangiocarcinoma
- Gallbladder Cancer
- Pancreatic Cancer
- Oesophageal Cancer
- Stomach Cancer
Timeline
- Start date
- 2020-10-28
- Primary completion
- 2025-06-30
- Completion
- 2025-06-30
- First posted
- 2022-08-05
- Last updated
- 2026-02-05
Locations
31 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT05489250. Inclusion in this directory is not an endorsement.